Forward Pharma wins EU patent
One of several legal disputes between the global biotech group Biogen and Denmark’s Forward Pharma has come to a conclusion – for now.
BY HENRIK TÜCHSEN
The small, Danish biotech company Forward Pharma, which has challenged one of the big dogs of the biotech world, US-based Biogen, in a remarkable legal showdown, has just won a patent in the EU, the company informs in a newswire.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Forward Pharma kicks off US patent war
For abonnenter
”Forward Pharma has been overlooked”
For abonnenter
Danish company to wage war on drug giant
For abonnenter
